Skip to main content
ADMA logo

ADMA

ADMA Biologics, Inc.

$8.68

2.14%

Trade Ideas Performance

Latest Closed Trade Idea

$8.68

2.14%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

8

Social

13

About

Events of ADMA Biologics, Inc. (ADMA)

In the past six months, ADMA Biologics' stock price has been impacted by several key events. A short-seller report in March 2026 led to a stock decline and securities fraud investigations, which the company refuted. In May 2026, Q1 earnings missed revenue estimates, leading to a lowered full-year forecast and stock decline. Also in May 2026, the FDA approved a label expansion for ASCENIV™ to include pediatric patients. In April 2025, ADMA received FDA approval for a production yield enhancement process.

Read more

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)
ADMA Biologics, Inc. (ADMA) Live Stock Price, Chart & Financial News | Edge Hound